NCT01629654

Brief Summary

Fatigue is a common complaint after stroke, reported by 39-72% of patients. Poststroke fatigue is related to poor neurological recovery, low level of activities of daily living, decreased quality of life and may possibly affect the ability to return to work. Little is known about strategies addressing post-stroke fatigue and their effectiveness. Aim: to develop, test and evaluate a health promotion program based on strategies addressing poststroke fatigue.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

January 20, 2012

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
26 days until next milestone

First Posted

Study publicly available on registry

June 27, 2012

Completed
Last Updated

June 27, 2012

Status Verified

June 1, 2012

Enrollment Period

1 year

First QC Date

January 20, 2012

Last Update Submit

June 25, 2012

Conditions

Keywords

Poststroke fatigueHealth promotionPatient education

Outcome Measures

Primary Outcomes (1)

  • Multidimensional Fatigue Inventory 20

    The multidimensional Fatigue Inventory 20 is a multidimensional fatigue score covering five dimensions of fatigue: General Fatigue, Physical Fatigue, Mental Fatigue, Reduced Motivation and Activity. Pathologic Fatigue is defined as a score ≥ 12 on the General Fatigue dimension.

    Change from baseline in MFI-20 at 3 and 6 months

Secondary Outcomes (1)

  • The general self-efficacy scale

    Change from baseline in the generel self-efficacy scale at 3 and 6 months

Study Arms (1)

Lifestyle counseling

EXPERIMENTAL

Testing of the teory- and evidence based health promotion program. Patients will participate in a 13 weeks program.

Behavioral: Health promotion program

Interventions

A 13 weeks organized program: * One group session about poststroke fatigue involving both patient and relatives * Two personal meetings, involving both patient and relatives * Three telephone meetings, involving only patient

Also known as: Poststroke fatigue, Complex interventions
Lifestyle counseling

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with first ever stroke
  • \> 18 year
  • Living in the area of Aarhus(intervention group) and patients living in the area of Holstebro (control group).
  • Multidimensional Fatigue Inventory-20/Generel Fatigue \> 12.
  • The patient must be able to give informed consent
  • Walking without person support.
  • Walking aids is accepted.

You may not qualify if:

  • Neurological problems related to acute stroke(severe aphasia, decreased level of conscience or decreased attention)
  • Other neurologic or psychiatric deseases (including dementia, non treated depression, misuse of alcohol eller medicin)
  • Severe co-morbidity (including cancer, blindness or deathness)
  • Not-danish speaking.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neurology, Aarhus University Hospital

Aarhus, Central Jutland, 8000, Denmark

Location

MeSH Terms

Conditions

Cardiovascular DiseasesStroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular Diseases

Study Officials

  • Marit Kirkevold, Professor

    University of Aarhus, Health, Nursing Science

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2012

First Posted

June 27, 2012

Study Start

March 1, 2011

Primary Completion

March 1, 2012

Study Completion

June 1, 2012

Last Updated

June 27, 2012

Record last verified: 2012-06

Locations